Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Hikma Pharmaceuticals Plc (HKMPF) Weighted-Average Shares Outstanding (Diluted) data is not available.
Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Weighted-Average Shares Outstanding (Diluted) |
-- |
-- |
|
-- |
|
Balance Sheet Financials | |
$2.56B |
|
$1.33B |
|
$3.00B |
|
$5.55B |
|
$2.06B |
|
$842.00M |
|
$947.00M |
|
$3.00B |
|
$2.55B |
|
$1.33B |
|
$2.55B |
|
-- |
|
Cash Flow Statement Financials | |
$161.00M |
|
$-215.00M |
|
$98.00M |
|
$188.00M |
|
$236.00M |
|
$48.00M |
|
$16.00M |
|
$-106.00M |
|
-- |
|
Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |